(Originally posted on July 2, 2019 and February 24, 2021.) If you enjoyed the GDATF’s patient bulletin “What’s Wrong With Me? I’m Not Myself Anymore”, then you won’t want to…
Did you miss our webinar on long-term use of antithyroid medication featuring Dr. Eve Bloomgarden (Northwestern Medicine) and Dr. David Cooper (Johns Hopkins Medicine)? See below to view the program in its entirety on YouTube!…
(Originally posted on December 8, 2020) To our valued community members, Wow, what a decade the last year has been! As 2020 kicked off, the future was so bright, we…
(Originally Posted on August 6, 2020) We were saddened to learn that Dr. Noel R. Rose, a pioneer in the field of autoimmunity and a former GDATF Board member, recently…
Did you know that the GDATF hosts a moderated Facebook group for patients? The group is closed – which means that group posts and comments can only be viewed by members. In order to join the group, visit our Facebook Page. Select…
(Originally posted January 21, 2020 and March 1, 2019) BREAKING NEWS: The FDA has approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease. Wiley Chambers, M.D., deputy director…
First Lady Barbara Bush (Originally Published on April 18, 2018): The staff and Board members of the Graves’ Disease & Thyroid Foundation (GDATF) would like to extend our condolences to…
Talk show host Wendy Williams from The Wendy Williams Show recorded a special greeting to kick off the Graves’ Disease & Thyroid Foundation’s 2018 Patient & Family Conference in San…
Have you asked your endocrinologist about the American Thyroid Association’s new guidelines for the management of hyperthyroidism? “These ATA guidelines, written by an international and multidisciplinary task force, provide a significant update…
***Update: Please click here to watch the segment!*** Don’t miss The Balancing Act airing on Lifetime Television® on March 12th & March 19th at 7:30 a.m. for a special segment on Graves’ disease!…
- « Previous
- 1
- 2
- 3
- 4
- Next »